Noémi Kreif

Health care resource utilization and costs in patients with acute myeloid leukemia treated with posttransplant maintenance therapy

Rachel Kneitel, Kyueun Lee, Noémi Kreif

BACKGROUND: Allogeneic hematopoietic cell transplantation (allo-HCT) improves survival in patients with acute myeloid leukemia (AML); however, posttransplant relapse remains the most common cause of treatment failure and death. Limited data exist on posttransplant health care resource utilization (HCRU) and costs, particularly for …

Machine Learning for Causal Inference: Opportunities and Pitfalls

Julia Hatamyar, Noémi Kreif

Abstract This article presents an overview of the uses of machine learning (ML) for causal inference. In addition to summarizing various methods for estimating average and conditional average treatment effects using ML under unconfoundedness, the article outlines advancements incorporating quasi-experimental methods, theoretical …

gb, us (code pays fourni par la source)

Does increasing overall health expenditure reduce inequality in under 5 mortality rates between provinces in Indonesia?

Iván Ochoa-Moreno, Noémi Kreif, Taufik Hidayat, Sari Kurnia et autres

While public health expenditure is widely assumed to reduce health inequalities, empirical evidence from low- and middle-income countries remains limited. This study examines whether increases in public health spending in Indonesia between 2010 and 2017 reduced inequalities in under-five mortality (U5MR). We …

gb, us, id (code pays fourni par la source)

MSR109 DETERMINING AN ECONOMICALLY JUSTIFIABLE PRICE FOR TRONTINEMAB IN EARLY ALZHEIMER’S DISEASE

Andrew Cotterill, Noémi Kreif

CO24 REAL-WORLD COMPARATIVE EFFECTIVENESS OF LUTETIUM-177-PSMA-617 VERSUS CABAZITAXEL FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

Ifechukwu B. Nwogu, Noémi Kreif, Hiba Khan, Ruth Etzioni et autres

us, Afrique du Sud (code pays fourni par la source)

CO69 HEALTHCARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH AML TREATED WITH POST-TRANSPLANT MAINTENANCE THERAPY

Rachel Kneitel, Kyu Lee, Noémi Kreif

us (code pays fourni par la source)

EE46 COST-EFFECTIVENESS OF ABIRATERONE, APALUTAMIDE, ENZALUTAMIDE, AND DOCETAXEL DOUBLETS FOR METASTATIC HORMONE-SENSITIVE PROSTATE CANCER: A REAL-WORLD EVIDENCE ANALYSIS

Ifechukwu B. Nwogu, Noémi Kreif, Hiba Khan, Ruth Etzioni et autres

Real-world comparative effectiveness of novel doublet therapies for metastatic hormone-sensitive prostate cancer.

Ifechukwu Benedict Nwogu, Noémi Kreif, Hiba M. Khan, Ruth Douglas Etzioni et autres

70 Background: Metastatic hormone-sensitive prostate cancer (mHSPC) is an advanced form of prostate cancer with a 5-year survival below 40%. Treatment guidelines recommend androgen deprivation therapy (ADT) combined with androgen receptor pathway inhibitors (ARPIs), docetaxel, or both. However, no head-to-head randomized trials …

us (code pays fourni par la source)

Transferability of Real World Evidence to Support HTA Recommendations in Lower Income European Countries

Zoltán Kaló, Guenka Petrova, B Bránné Németh, Petra Došenović Bonča et autres

Background and Aims Lower income European countries (LIECs) have more limited financial resources to cover high-cost technologies in rare diseases than higher income European countries (HIECs). Our study explores how treatment recommendations in myelodysplastic syndrome (MDS) can be supported in LIECS by …

Transferability of Real World Evidence to Support HTA Recommendations in Lower Income European Countries

Zoltán Kaló, Guenka Petrova, Bertalan Németh, Petra Došenović Bonča et autres

Background and Aims: Lower income European countries (LIECs) have more limited financial resources to cover high-cost technologies in rare diseases than higher income European countries (HIECs). Our study explores how treatment recommendations in myelodysplastic syndrome (MDS) can be supported in LIECS by …

hu, bg, si, nl, gb, pl, sk, se, ro, ua, cz, kz, hr (code pays fourni par la source)

Depression Symptoms, Employment, and Household Economic Outcomes: Evidence from the MIND-ECON Trial in South Africa

Samuel Lordemus, Nikita Jacob, Marc Suhrcke, Rowena Jacobs et autres

ch, gb, lu, Afrique du Sud (code pays fourni par la source)

Estimating the Causal Effect of Realistic Treatment Strategies Using Longitudinal Observational Data

Yingying Zhang, A. H. Bennett, Andrea Manca, Moshe Mittelman et autres

BackgroundReal-world data can inform health care decisions by allowing the evaluation of nuanced treatment strategies. Longitudinal observational data enable the assessment of dynamic treatment regimes (DTRs), strategies that adapt treatment over time based on patient history, but require causal inference methods to …

gb, il, nl, at, it, us (code pays fourni par la source)